BrightSpring Health Services, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $12.91B | $10.07B | $7.69B | $7.72B |
| Cost of Revenue | — | — | — | — |
| Gross Profit | $1.52B | $1.27B | $1.14B | $1.35B |
| Gross Margin | 11.8% | 12.6% | 14.8% | 17.5% |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | $1.22B | $1.16B | $1.08B | $1.13B |
| Operating Income | $295.3M | $108.0M | $58.1M | $187.8M |
| Operating Margin | 2.3% | 1.1% | 0.8% | 2.4% |
| Interest Expense | $157.3M | $190.5M | $271.9M | $233.6M |
| Pretax Income | $137.9M | $-95.3M | $-213.8M | $-45.8M |
| Income Tax Expense | $33.1M | $-26.4M | $-31.5M | $33.1M |
| Net Income | $190.7M | $-18.1M | $-154.6M | $-53.9M |
| Net Margin | 1.5% | -0.2% | -2.0% | -0.7% |
| EPS (Basic) | $0.94 | $-0.09 | $-1.31 | $-0.46 |
| EPS (Diluted) | $0.87 | $-0.09 | $-1.31 | $-0.46 |
| Shares Outstanding (Basic) | 202.6M | 193.0M | 117.9M | 117.8M |
| Shares Outstanding (Diluted) | 219.8M | 193.0M | 117.9M | 117.8M |
| Dividends Per Share | — | — | — | — |